-The Economic Times   Pushed to the wall by an overly cautious drug regulator and an alarmist Indian government, clinical trial companies are looking at South East Asian countries to expand their business and escape the red tape of Indian authorities.  Clinical research companies (CROs), that were aspiring to become billion- dollar companies by 2010, had to rework their plans after a Parliamentary Standing Committee report questioned the allegedly unfair and unethical trials...

-The Hindu Human Rights Watch (HRW), an international human rights body, has urged the government of India to probe the fresh allegations of human rights violations by the personnel of the Border Security Force (BSF) along the Bangladesh border and prosecute those responsible. According to HRW's latest report, despite assurances to Bangladesh and public orders to end unlawful killings and attacks on suspected smugglers, evidence documented and published by Indian and Bangladeshi...

-The Hindu States told to have contingency plans ready, post-delay in onset in Kerala   Agriculture experts and officials are closely monitoring the advance of the southwest monsoon, which is crucial not only for the important summer kharif crop but also the socio-economic wellbeing of the country. There are apprehensions that with farm growth having slowed down in the pre-wheat harvest quarter to 1.7 per cent, if the monsoon were to be deficient, then...

-Reuters Monsoon rains were 36 percent below average in the week to June 6, the weather office said on Thursday, reflecting the delay in the arrival of the seasonal rains over south India from the usual June 1 start date. The four-month long rainy season is in the initial stages and crops are not greatly affected by the quantity of rains now, with distribution of rainfall in mid-July after the monsoon covers...

-The Hindu The World Health Organisation (WHO) has put in place a mechanism to define counterfeit medical products. The set of definitions of sub-standard, spurious, falsely labelled, falsified and counterfeit products will be globally accepted and help to bring about uniformity in identifying such drugs, without interrupting worldwide supplies. The decision to establish a member state mechanism was taken at the World Health Assembly, the WHO's policymaking body, at a meeting held recently. The...